CIK 0001029125
PBLA Panbela Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Nov 19, 2024.
In brief
Panbela Therapeutics, Inc. (PBLA) has 1 SEC Form 4 filing on file from 1 insider, the latest filed on Nov 19, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Panbela Therapeutics, Inc., scored.
Transactions
Every row filed, 1 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Nant Capital, LLC owner | POpen-market purchase 8% Senior Convertible Note due 2025derivative | - | $9,150,000.00 | - | - | Nov 19, 2024 |
Questions about PBLA
Answered from the filings on this page, as of the latest one.
Are insiders buying PBLA?
No. In the last 90 days no insider at Panbela Therapeutics, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade PBLA on the open market?
No open-market trade has been scored at Panbela Therapeutics, Inc.. The latest Form 4 on file was filed on Nov 19, 2024 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Panbela Therapeutics, Inc.?
1 person has filed a Form 4 at Panbela Therapeutics, Inc., among them Nant Capital, LLC (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.